Pulmonary Embolism
534
56
73
299
Key Insights
Highlights
Success Rate
89% trial completion (above average)
Published Results
68 trials with published results (13%)
Research Maturity
299 completed trials (56% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
7.1%
38 terminated out of 534 trials
88.7%
+2.2% vs benchmark
18%
98 trials in Phase 3/4
23%
68 of 299 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 299 completed trials
Clinical Trials (534)
Contribution of Lower Limb Venous Colour Doppler Ultrasound in the Diagnosis of Pulmonary Embolism Recurrence
Evaluation of Precision and Accuracy of INR Measurements in a Point of Care Device
A Performance Evaluation of the LumiraDx Point Of Care D-dimer Assay
Pulmonary Artery Pressure in Predicting Pulmonary Embolism in Patients Presenting To The Emergency Department With Dyspnea
The PEERLESS II Study
FUVID Study: Functional Characterization of Children With Chronic Venous Thromboembolic Disease
Ultrasound-facilitated, Catheter-directed, Thrombolysis in Intermediate-high Risk Pulmonary Embolism
Inari VISION Registry
The PERSEVERE Study
Point-of-Care Ultrasound in Predicting Adverse Outcomes in Emergency Department Patients With Acute Pulmonary Embolism
Michigan Emergency Department Improvement Collaborative (MEDIC) Alert; Pulmonary Embolism (PE)
STRATEGY-PE: Real-World Treatment Strategies for Intermediate-High Risk Pulmonary Embolism
Clinical Surveillance vs. Anticoagulation for Low-risk Patients With Isolated Subsegmental Pulmonary Embolism
Selective Pulmonary-artery Intervention to Reduce Acute Right-heart tEnsion-I
Does COVID-19 Infection Increase the Risk of Pulmonary Embolism?
Aspiration Thrombectomy Using the Symphony or Prodigy System
Study of the Long-Term Safety and Outcomes of Treating Pulmonary Embolism With the Indigo Aspiration System
Pulmonary Embolism - Thrombus Removal With Catheter-Directed Therapy
Genetic Markers of Patients With History of Pulmonary Embolism Post Total Joint Arthroplasty
Percutaneous Embolectomy, Low Dose Thrombolysis or Heparin for Intermediate High Risk Pulmonary Embolism (STRATIFY II)